Judge partially revives California ‘pay for delay’ pharma deals that limit generic drugs
A federal judge has partially revived California’s “pay for delay” law, which prohibits pharmaceutical companies from paying competitors to keep generic drugs off the market. But the law’s author said the latest ruling would still allow companies to sidestep enforcement.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
